| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9860a6a28a9e6084ee462bcfbd9e15dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5c1a92dd472e17be380f70e5dfb8dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f36ca511ff6f6fd755f640dab3c1f770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3cabe9863448209dcca52f959e58d3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eb88fd118aec74c3f093ef269f594ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3f3769b7f0409a3d80cca6feb2062b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29ae15607864678240b53abaac3cad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce8377b596555eafc556f7c273b6adf |
| publicationDate |
2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006123502-A1 |
| titleOfInvention |
Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals |
| abstract |
Provided is a human RE2-L protein, as well as the encoding nucleic acid, methods for screening for agents capable of modulating RE2-L related activity and treating RE2-L-mediated conditions. Further provided are animal models useful for screening agents capable of ameliorating or reducing anxiety related disorders and obsessive-compulsive disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011173706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009142724-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009142724-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012068065-A3 |
| priorityDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |